We think that the sensitivity and specificity of the test would be reduced in patients including those with angiotensin II-responsive adenomas, because it is possible that the increased autonomous aldosterone secretion reduces the responsiveness of aldosterone secretion in simple standing test. The gene discussed is AGT; the disease is adenoma.